A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT06341335 · RECRUITING
Trial details
- NCT number
- NCT06341335
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-11-01
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.